Literature DB >> 30975822

Two heads are better than one: benefits of joint models for ALS trials.

Ruben P A van Eijk1,2, James Rooney3, Orla Hardiman3,4, Leonard H van den Berg5.   

Abstract

Entities:  

Keywords:  als; epidemiology; motor neuron disease; statistics

Year:  2019        PMID： 30975822     DOI： 10.1136/jnnp-2019-320553

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  2 in total

1.  Composite endpoint for ALS clinical trials based on patient preference: Patient-Ranked Order of Function (PROOF).

Authors:  Ruben P A van Eijk; L H van den Berg; Ying Lu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-12-17       Impact factor: 13.654

2.  Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.

Authors:  Ruben P A van Eijk; Stavros Nikolakopoulos; Kit C B Roes; Bas M Middelkoop; Toby A Ferguson; Pamela J Shaw; P Nigel Leigh; Ammar Al-Chalabi; Marinus J C Eijkemans; Leonard H van den Berg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-07-10       Impact factor: 10.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.